Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Revenue	$ 0	$ 0
Operating expenses:
General and administrative (including stock-based compensation (Note 6))	2,349,060	3,762,427
Research and development (including stock-based compensation (Note 6))	48,606	70,134
Total operating expenses	2,397,666	3,832,561
Loss from operations	(2,397,666)	(3,832,561)
Other expense (income):
Interest expense	55,316	7,215
Interest income	(50)	(1,007)
	55,266	6,208
Net loss	(2,452,932)	(3,838,769)
Net loss attributable to the noncontrolling interest	1,398	13,103
Net loss attributable to Bion	(2,451,534)	(3,825,666)
Conversion inducement		(548,580)
Dividends on preferred stock	(1,667)	(149,550)
Net loss applicable to Bion's common stockholders	$ (2,453,201)	$ (4,523,796)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in Dollars per share)	$ (0.14)	$ (0.34)
Weighted-average number of common shares outstanding:
Basic and diluted (in Shares)	16,927,270	13,450,823